MTHFR GENE MUTATION, QUALITATIVE PCR
MRP - ₹ 3,500
What is a MTHFR GENE MUTATION, QUALITATIVE PCR?
The **MTHFR Gene Mutation, Qualitative PCR test** is a genetic test that detects mutations in the *methylenetetrahydrofolate reductase (MTHFR)* gene using polymerase chain reaction (PCR) technology. This gene plays a key role in folate metabolism and homocysteine regulation. Mutations can increase the risk of cardiovascular disease, blood clotting disorders, pregnancy complications, and certain neurological conditions. The test is performed to identify whether these mutations are present, helping clinicians assess genetic risk factors and guide preventive or therapeutic strategies.
Additional Information
| Also known as/ Other names: | MTHFR Mutation Analysis, MTHFR PCR Test, MTHFR Gene Polymorphism Test, Methylenetetrahydrofolate Reductase Mutation Test |
| Parameters: | 1 |
| Recommended for: | M/F/Others |
| Sample Type: | Blood |
| Patient Preparation: | No prior preparation is needed |
| Reports: | 3 working days |
FAQs
A positive result indicates the presence of an MTHFR mutation, which may increase risk for certain health conditions.
A negative result means no detectable MTHFR mutations, reducing the likelihood of related genetic risks.
Individuals with unexplained blood clots, recurrent pregnancy loss, or family history of cardiovascular disease may benefit from this test.
No, it only detects genetic mutations. Clinical evaluation and other tests are needed to diagnose cardiovascular disease.
No, it is diagnostic. Clinical monitoring and biochemical tests track treatment response.
Not necessarily. It indicates genetic risk, but lifestyle and other factors also influence disease development.
Yes, certain mutations are linked to recurrent miscarriages, preeclampsia, and neural tube defects.